BioCurate’s Proof-of-Concept Fund Increased

Author

Date

BioCurate

August 1, 2023

Projects awarded POC funding from the next round of project applications will now be able to access up to $500k.

With renewed funding from its Shareholders universities, BioCurate continues its mission to translate discoveries from Victoria’s world-class bioscience laboratories into high quality therapies that can save and improve people’s lives. BioCurate is pleased to announce a significant project funding increase to its successful Proof-of-Concept (POC) Fund. Projects awarded POC funding from the next round of project applications will now be able to access up to $500K of funding over a period of 12-18 months, to accelerate therapeutic discoveries.

BioCurate is pleased to be able to announce an increase in POC project funding of up to $500K. We are building on the success and excellent momentum we have been able to generate since the POC fund’s inception. With the increase in funding, we look forward to continuing to fund those early stage projects with the greatest commercial potential, provide further support for researchers, and ensure the greatest chance of a tangible commercial outcome.” – Dr Christopher Chan, BioCurate Executive Director, Research and Development

The POC Fund is designed to support both early-stage and more mature projects that require additional experimental validation to address key scientific gaps, and to generate additional compelling data to de-risk projects to reach the next value inflection point. In addition to funding, Researchers will benefit from BioCurate’s industry expertise and mentoring in crafting commercialisation and IP strategies, as well as designing experimental plans to address key project risks. During the project, BioCurate staff are on hand to provide support to the investigators to maximise the chances of reaching a successful outcome. For POC projects successfully completing milestones, BioCurate offers a path to commercialisation with licensing opportunities and further investment (up to $10 million tranched funding).

This funding scheme is open to both University of Melbourne and Monash University research projects, as well as from affiliated Victorian Medical Research Institutes.

Investigators retain ownership of the IP rights in the Technology and will own any improvements to its Background IP and IP arising from the performance of the POC Project.

Application forms are succinct and easy to complete, and researchers are encouraged to submit an application to accelerate the translation of their therapeutic discovery.

Call for BioCurate Opportunity Assessment (BOA) applications open 7 August 2023 and close 15 September 2023.

BioCurate invites Researchers and Commercialisation Managers to attend our information sessions to be held on Wednesday August 9 at Melbourne Connect and Thursday August 10 at Monash University Clayton to find out about BioCurate investment opportunities, eligibility and success criteria and the funding process.

Registrations are required for our Melbourne Connect information session. Click here for more information and to register via Eventbrite.

For further information, contact Dr Andy Allen (a.allen@biocurate.com) and info@biocurate.com.

Share